相关阅读

Array ( [0] => Array ( [relateid] => 808294 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/808294.html [wapUrl] => https://m.jnnc.com/p/808294.html [published_timestamp] => 1603243132 [published] => 1603243132 [pv] => 106 [virtual_pv] => 0 [all_pv] => 106 [title] => 韩国发生第3例接种流感疫苗死亡病例：82岁男性，接种仅数小时 [has_thumb] => 0 [thumb] => ) [1] => Array ( [relateid] => 807168 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/807168.html [wapUrl] => https://m.jnnc.com/p/807168.html [published_timestamp] => 1601348690 [published] => 1601348690 [pv] => 142 [virtual_pv] => 0 [all_pv] => 142 [title] => 全国流感防控工作方案发布：降低重点人群疫苗接种费用 [has_thumb] => 0 [thumb] => ) [2] => Array ( [relateid] => 808197 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/808197.html [wapUrl] => https://m.jnnc.com/p/808197.html [published_timestamp] => 1603162833 [published] => 1603162833 [pv] => 194 [virtual_pv] => 0 [all_pv] => 194 [title] => 好消息！国内两地已开始打新冠疫苗！ [has_thumb] => 0 [thumb] => ) [3] => Array ( [relateid] => 808271 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/808271.html [wapUrl] => https://m.jnnc.com/p/808271.html [published_timestamp] => 1603239085 [published] => 1603239085 [pv] => 184 [virtual_pv] => 0 [all_pv] => 184 [title] => 我国新冠病毒疫苗III期临床试验已接种约6万人 未收到严重不良反应报告 [has_thumb] => 0 [thumb] => ) [4] => Array ( [relateid] => 808266 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/808266.html [wapUrl] => https://m.jnnc.com/p/808266.html [published_timestamp] => 1603180556 [published] => 1603180556 [pv] => 179 [virtual_pv] => 0 [all_pv] => 179 [title] => 我国4个新冠疫苗进入临床三期，6万人接种无严重不良反应 [has_thumb] => 0 [thumb] => ) )
• 韩国发生第3例接种流感疫苗死亡病例：82岁男性，接种仅数小时
• 全国流感防控工作方案发布：降低重点人群疫苗接种费用
• 好消息！国内两地已开始打新冠疫苗！
• 我国新冠病毒疫苗III期临床试验已接种约6万人 未收到严重不良反应报告
• 我国4个新冠疫苗进入临床三期，6万人接种无严重不良反应